MoneyWorks4Me

Nectar Lifesciences informs about disclosures

04 Oct 2024 Evaluate
Nectar Lifesciences has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ISENGARD Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..